R&D

R&D

Oncology
Abemaciclib
Alpelisib
Capivasertib
Apalutamide
Pomalidomide
Tazemetostat

Cytotoxin

Anti-diabetic
Bexagliflozin
Semaglutide
Sotagliflozin
Tirzepatide
Cagrilintide
Retatrutide